Related Experiment Videos
[The effect of IL-2 injection around the metastatic cervical lymphnode]
H Ogasawara1, N Takeda, N Takeda
1Department of Otolaryngology, Hyogo College of Medicine.
Nihon Gan Chiryo Gakkai Shi
|June 20, 1990
Summary
Interleukin-2 (IL-2) injections increased Lymphokine Activated Killer (LAK) cell activity in head and neck cancer patients. This immunotherapy approach showed promising results, with one patient achieving a partial response.
Area of Science:
- Immunology
- Oncology
- Biotherapy